We are live on
!
Find out more
BWLSA
Blue Water Life Science Advisors Portfolio holdings
AUM
$159M
1-Year Est. Return
139.66%
This Fund
S&P 500
This Quarter
Est. Return
+10.42%
1 Year Est. Return
+139.66%
3 Year Est. Return
+503.09%
5 Year Est. Return
+228.74%
10 Year Est. Return
–
AUM
$113M
AUM Growth
-$769K
(-0.68%)
Cap. Flow
-$4.37M
Cap. Flow
% of AUM
-3.87%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
2
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Guardant Health
GH
|
+$6.84M |
| 2 |
TEM
Tempus AI
TEM
|
+$4.45M |
| 3 |
Personalis
PSNL
|
+$613K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXAS
Exact Sciences
EXAS
|
+$11M |
| 2 |
Natera
NTRA
|
+$5.29M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
SFC
ACP
CW
SG
LA
CMMS
JWM
AC
Blue Water Life Science Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Blue Water Life Science Advisors held 9 positions worth $113M, down 0.68% from $114M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Blue Water Life Science Advisors withdrew a net $4.37M in Q4 2024, reducing 2 holdings. Its largest reduction was Exact Sciences, cutting an estimated $11M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
Against the trend, Blue Water Life Science Advisors opened a new position in Tempus AI worth $3.04M.
- Blue Water Life Science Advisors's largest Q4 2024 buy was Tempus AI: 90,000 shares worth $3.04M.
- Blue Water Life Science Advisors added most to Guardant Health in Q4 2024, an estimated $6.84M increase.
- Blue Water Life Science Advisors's biggest Q4 2024 reduction was Exact Sciences, cutting an estimated $11M.
- Blue Water Life Science Advisors's ten largest holdings make up 100% of its $113M portfolio in Q4 2024.
- Blue Water Life Science Advisors opened 1 new position and closed 0 in Q4 2024.
- Blue Water Life Science Advisors's portfolio value fell 0.68% quarter-over-quarter to $113M.
Based on Blue Water Life Science Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.